Lung Cancer Clinical Trials
Find clinical trials for lung cancer. Search for lung cancer clinical trials in different cities and states across the United States.
GlumetinibAssessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
Sponsor:
Haihe Biopharma Co., Ltd.
Location:
Code:
NCT04270591
Conditions
C-Met Exon 14 Mutation
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Glumetinib
[18F]-ML-10An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
Sponsor:
Aposense Ltd.
Location:
Code:
NCT01260480
Conditions
Carcinoma, Non-Small-Cell Lung
Head and Neck Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
[18F]-ML-10 in conjunction with PET imaging
Chemotherapy & ImmunotherapyChemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05001880
Conditions
Peritoneal Malignant Mesothelioma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Atezolizumab
Bevacizumab
Biospecimen Collection
Carboplatin
Computed Tomography
MGY825Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT05275868
Conditions
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
MGY825
Valemetostat Tosylate & PembrolizumabA Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
Sponsor:
Daiichi Sankyo
Location:
Code:
NCT06644768
Conditions
Non-small Cell Lung Cancer
Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
valemetostat tosylate
pembrolizumab
AZD5305Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
Sponsor:
AstraZeneca
Location:
Code:
NCT04644068
Conditions
Ovarian Cancer
Breast Cancer
Pancreatic Cancer
Prostate Cancer
Additional Indications Below for Module 4 and 5
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
AZD5305
Paclitaxel
Carboplatin
T- Dxd
Dato-DXd
Pembrolizumab vs. Sacituzumab GovitecanStudy of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-3475-D46)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT05609968
Conditions
Carcinoma, Non-Small-Cell Lung
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sacituzumab Govitecan
Pembrolizumab
AZD5335Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Sponsor:
AstraZeneca
Location:
Code:
NCT05797168
Conditions
Ovarian Cancer
Lung Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
AZD5335
Saruparib (AZD5305)
Bevacizumab
Carboplatin
Observational StudyImproving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
Sponsor:
OHSU Knight Cancer Institute
Location:
Code:
NCT05407168
Conditions
Lung Carcinoma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Best Practice
Health Promotion and Education
Questionnaire Administration
SutetinibA Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Sponsor:
Teligene US
Location:
Code:
NCT06010329
Conditions
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sutetinib Maleate Capsule